139 related articles for article (PubMed ID: 15534007)
1. Improving psychiatric drug benefit management: IV. Experiences of a pharmacy advisory committee.
Gottlieb D; Dubin WR; Ning A; Gardiner GC
Psychiatr Serv; 2004 Nov; 55(11):1210-2. PubMed ID: 15534007
[No Abstract] [Full Text] [Related]
2. Using clinical evidence to manage pharmacy benefits: experiences of six states.
Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
[TBL] [Abstract][Full Text] [Related]
3. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses.
Donohue JM
Psychiatr Serv; 2005 Jun; 56(6):645-7. PubMed ID: 15939937
[No Abstract] [Full Text] [Related]
4. Managed care: improving psychiatric drug benefit management: I. Lessons from Massachusetts.
Sabin JE; Daniels N
Psychiatr Serv; 2003 Jul; 54(7):949-51. PubMed ID: 12851429
[No Abstract] [Full Text] [Related]
5. Medicare part D and decompensation.
Park JM; Hariprasad R; Park LT
Psychiatr Serv; 2006 May; 57(5):722-3. PubMed ID: 16675773
[No Abstract] [Full Text] [Related]
6. Pharmaceuticals & psychotropic drugs.
Health Aff (Millwood); 2009; 28(3):723. PubMed ID: 19414880
[No Abstract] [Full Text] [Related]
7. Medication cost-cutting plans burden patients and clinicians.
Albright B
Behav Healthc; 2015; 35(1):20, 22-4. PubMed ID: 25764698
[No Abstract] [Full Text] [Related]
8. Mental health policy and psychotropic drugs.
Frank RG; Conti RM; Goldman HH
Milbank Q; 2005; 83(2):271-98. PubMed ID: 15960772
[TBL] [Abstract][Full Text] [Related]
9. Potential cost savings from pill splitting of newer psychotropic medications.
Cohen CI; Cohen SI
Psychiatr Serv; 2000 Apr; 51(4):527-9. PubMed ID: 10737832
[TBL] [Abstract][Full Text] [Related]
10. Improving psychiatric drug benefit management: II. Kaiser Permanente's approach to SSRIs.
Sabin JE; Daniels N
Psychiatr Serv; 2003 Oct; 54(10):1343-4,1349. PubMed ID: 14557518
[No Abstract] [Full Text] [Related]
11. Improving mental health treatments through comparative effectiveness research.
Wang PS; Ulbricht CM; Schoenbaum M
Health Aff (Millwood); 2009; 28(3):783-91. PubMed ID: 19414887
[TBL] [Abstract][Full Text] [Related]
12. Economic grand rounds: potential effects of the new medicare drug benefit on pricing for psychotropic medications.
Huskamp HA; Shinogle JA
Psychiatr Serv; 2005 Sep; 56(9):1056-8. PubMed ID: 16148317
[No Abstract] [Full Text] [Related]
13. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
[TBL] [Abstract][Full Text] [Related]
14. Dual eligibles with mental disorders and Medicare part D: how are they faring?
Donohue JM; Huskamp HA; Zuvekas SH
Health Aff (Millwood); 2009; 28(3):746-59. PubMed ID: 19414883
[TBL] [Abstract][Full Text] [Related]
15. Managing psychotropic drug costs: will formularies work?
Huskamp HA
Health Aff (Millwood); 2003; 22(5):84-96. PubMed ID: 14515884
[TBL] [Abstract][Full Text] [Related]
16. Implications of Part D for mentally ill dual eligibles: a challenge for Medicare.
Morden NE; Garrison LP
Health Aff (Millwood); 2006; 25(2):491-500. PubMed ID: 16522603
[TBL] [Abstract][Full Text] [Related]
17. Psychopharmacology: the need for effectiveness trials to inform evidence-based psychiatric practice.
Lagomasino IT; Dwight-Johnson M; Simpson GM
Psychiatr Serv; 2005 Jun; 56(6):649-51. PubMed ID: 15939939
[No Abstract] [Full Text] [Related]
18. An outcomes-based approach to decisions about drug coverage policies in British Columbia.
Morgan S; Bassett K; Mintzes B
Psychiatr Serv; 2004 Nov; 55(11):1230-2. PubMed ID: 15534010
[No Abstract] [Full Text] [Related]
19. Learn nothing, forget nothing--the Medicare Commission redux.
Vladeck BC
N Engl J Med; 2001 Aug; 345(6):456-8. PubMed ID: 11496859
[No Abstract] [Full Text] [Related]
20. High-cost use of second-generation antipsychotics under California's Medicaid program.
Stahl SM; Grady MM
Psychiatr Serv; 2006 Jan; 57(1):127-9. PubMed ID: 16399974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
